SCIENTIFIC ADVISORY BOARD
Dr. Nakhle Saba—Our Lady of the Lake Cancer Institute/LSU Health Sciences Center
Dr. Saba earned his medical degree from the Lebanese University in Beirut 2005. He completed his residency in Internal Medicine at East Tennessee State University in Johnson City, TN and Tulane University in New Orleans, LA, and his fellowship in Hematology and Medical Oncology at Tulane University. After fellowship completion in 2011, Dr. Saba joined the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH) for an additional fellowship in lymphoid malignancies. His research at the NIH was focused on tumor biology and developing new therapeutic approaches for leukemia and lymphoma. He returned to Tulane in 2014 as Assistant Professor of Medicine, promoted to Associate Professor in 2018, then to Professor in 2024 following a successful career in research, teaching, and treating blood cancers. Dr. Saba’s research focuses on lymphoid malignancies and cell therapy, to identify therapeutic targets and novel drugs for these diseases.
Dr. Saba authored and/or co-authored more than 120 published manuscripts and research abstracts, he presented at regional, national, and international meetings as a researcher and invited speaker. His articles appear in journals like Blood, Leukemia, Cancer Research, The Lancet Haematology, Haematologica, Science Advances, Bone Marrow Transplant and others. Click to access Dr. Saba’s Bibliography on PubMed or Dr. Saba’s Articles, Abstracts, and Citations
On October 1, 2024, Dr. Saba was recruited at the Our Lady of the Lake Cancer Institute as Professor of Medicine at LSU Health Sciences Center, and Director of Lymphoma, CLL, and chimeric antigen receptor (CAR)-T. He will be diligently working to expand the lymphoma and CLL research portfolio and bring cutting edge therapies to the region such as CAR-T, the next generation CARs
Staying in the Moment: How MCED Tests Could Transform Cancer Care in Louisiana
I’ll never forget how I felt when my doctor told me I had Hodgkin’s Lymphoma. I was 20 years old and was just told I have a 50% chance of surviving. I’ll also never forget how the outlook could’ve been even more grim had my cancer not been detected as early as it was....
CAGLA adds 8 new members to their Scientific Advisory Board
CAGLA’s Scientific Advisory Board (SAB) is comprised of some of the top healthcare providers from across Louisiana. Our SAB members provide strategic guidance and direction for our CAGLA state legislative initiatives and for our annual NeauxCancer Oncology Conference....
CAGLA gives 2023 Scientific Advisory Board Member of the Year Award to Dr. Ralph Corsetti
6th of December, 2023, New Orleans, Louisiana — CAGLA’s Scientific Advisory Board (SAB) is comprised of some of the top healthcare providers from across Louisiana. Our SAB members provide strategic guidance and direction for our CAGLA state legislative initiatives and...
Your Support Matters
Donate to CAGLA CARES and make a real, lasting difference in our state’s cancer care.
RECENT NEWS
Staying in the Moment: How MCED Tests Could Transform Cancer Care in Louisiana
I’ll never forget how I felt when my doctor told me I had Hodgkin’s Lymphoma. I was 20 years old and was just told I have a 50% chance of surviving. I’ll also never forget how the outlook could’ve been even...
EXPLORE CAGLA
MAKE A DIFFERENCE
Each donation strengthens our efforts towards innovative legislation, advanced cancer research, and enhanced patient care. Back our cause, help us realize a cancer-free Louisiana.